BiomeBank, South Australian biotechnology company, has submitted its world-first biologic drug product to the Therapeutic Goods Administration for market authorisation.
Read More
Moderna vaccine manufacturing capacity confirmed in Budget
The federal government has secured 25 million doses of the Moderna COVID-19 vaccine, providing access to a booster or variant vaccine if it is required in the future.
It was confirmed in the 2021-22
Read More
Read More